Evidence map›Paper›PMID 25310116›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2014

Improving PMTCT uptake and retention services through novel approaches in peer-based family-supported care in the clinic and community: a 3-arm cluster randomized trial (PURE Malawi).

Nora E Rosenberg, Monique van Lettow, Hannock Tweya, Atupele Kapito-Tembo, Cassandre Man Bourdon, Fabian Cataldo, Levison Chiwaula, Veena Sampathkumar, Clement Trapence, Virginia Kayoyo and 8 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Nora E Rosenberg*University of North Carolina Project, Lilongwe, Malawi; †Dignitas International, Zomba, Malawi; ‡Dalla Lana School of Public Health, University of Toronto, Toronto, Canada; §Lighthouse Trust, Lilongwe, Malawi; ‖The International Union Against Tuberculosis and Lung Disease, Paris, France; ¶University of Malawi College of Medicine, Blantyre, Malawi; #University of Malawi Chancellor College, Zomba, Malawi; **Mothers2Mothers, Lilongwe, Malawi; ††Management Sciences for Health, Lilongwe, Malawi; and ‡‡Ministry of Health, Lilongwe, Malawi.
Monique van Lettow
Hannock Tweya
Atupele Kapito-Tembo
Cassandre Man Bourdon
Fabian Cataldo
Levison Chiwaula
Veena Sampathkumar
Clement Trapence
Virginia Kayoyo
Florence Kasende
Blessings Kaunda
Colin Speight
Erik Schouten
Michael Eliya
Mina Hosseinipour
Sam Phiri
PURE Malawi Consortium
Lighthouse Trust · MWDignitas International · MWInternational Union Against Tuberculosis and Lung Disease · FRManagement Sciences for Health · USMinistry of Health · MW

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Fogarty Global Health Fellows Coordinating CenterR25TW009340 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHI, BENJAMIN H. · 2012 to 2016
$6.9M
FIC NIH HHS NIH 1R25TW09340-01FIC NIH HHS R25 TW009340NIAID NIH HHS NIH P30-AI50410NIAID NIH HHS P30 AI050410
6 · The paper itself

Abstract

In July 2011, Malawi introduced an ambitious public health program known as "Option B+," which provides all HIV-infected pregnant and breastfeeding women with lifelong combination antiretroviral therapy, regardless of clinical stage or CD4 count. Option B+ is expected to have benefits for HIV-infected women, their HIV-exposed infants, and their HIV-uninfected male sex partners. However, these benefits hinge on early uptake of prevention of mother-to-child transmission, good adherence, and long-term retention in care. The Prevention of mother-to-child transmission Uptake and REtention (PURE) study is a 3-arm cluster randomized controlled trial to evaluate whether clinic- or community-based peer support will improve care-seeking and retention in care by HIV-infected pregnant and breastfeeding women, their HIV-exposed infants, and their male sex partners, and ultimately improve health outcomes in all 3 populations. We describe the PURE Malawi Consortium, the initial work conducted to inform the trial and interventions, the trial design, and the analysis plan. We then discuss concerns and expected contributions to Malawi and the region.

Indexed as

FamilyPatient CompliancePeer GroupAnti-HIV AgentsFemaleHIV InfectionsHumansInfant, NewbornInfectious Disease Transmission, VerticalMalawiPregnancyPregnancy Complications, InfectiousSample SizeAnti-HIV Agents

Identifiers

PMID25310116
PMCPMC4197136
OpenAlexW1999648205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.